NanoVation Therapeutics Announces Multi-Target Partnership with Novo Nordisk to Develop Genetic Medicines Targeting Cardiometabolic and Rare Diseases
Under the terms of the agreement, Novo Nordisk and NanoVation [...]
Under the terms of the agreement, Novo Nordisk and NanoVation [...]
MindLight is the first circular RNA biomarker-based assay designed to [...]
“We are thrilled to obtain the CE mark for our [...]
PHC Corporation Biomedical Division (Headquarters: Chiyoda-ku, Tokyo; President: Nobuaki Nakamura, [...]
By leveraging its ultra-intensified fed-batch platform, WuXiUI, WuXi Biologics has [...]
The new ICMRA program is designed to abbreviate the time [...]
“Our Nanovial Multicell Assays are a game-changer, opening up new [...]
“This project represents a paradigm shift towards improving viral vector [...]
HT-KIT cancer therapeutic is an antisense oligonucleotide that targets the [...]
NEC Bio Therapeutics, a Mannheim based German company focused on [...]